Litigation Details for Silbersher v. Valeant Pharmaceuticals International, Inc (N.D. Cal. 2018)
✉ Email this page to a colleague
Silbersher v. Valeant Pharmaceuticals International, Inc (N.D. Cal. 2018)
Small Molecule Drugs cited in Silbersher v. Valeant Pharmaceuticals International, Inc
Biologic Drugs cited in Silbersher v. Valeant Pharmaceuticals International, Inc
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Silbersher v. Valeant Pharmaceuticals International, Inc (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-03-08 | 1 | Complaint | the Otterbeck Patents. 26 4 27 The Otterbeck Patents are U.S. Patent Nos. 6,551,620 ("the …Otterbeck Patent to be approved, United States 21 Patent No. 6,551,620 ("the '620 Patent"…See e.g., U.S. Patent No. 6,551,620 at col. 5, lines 15-19. 4 70. Apriso® is a granulated…. Patent No. 8,865,688 ("the '688 Patent"). The '688 Patent was issued 3 on October… United States Patent Law 11 64. United States patents grant the patent owner or assignee | External link to document |
2018-10-23 | 10 | Amended Complaint | Otterbeck Patent to be approved, United States Patent No. 6,551,620 (“the ’620 Patent”). The ’620 Patent issued… Patent Nos. 6,551,620 (“the 7620 Patent”), 8,337,886 (“the ’886 Patent”), 8,496,965 (“the ’965 Patent….g., U.S. Patent No. 6,551,620 at col. 5, lines 15-19. 76. Apriso® is a granulated mesalamine formulation…knew that ’990 Patent, the’742 Patent, the ’858 Patent, and the “EP0169821A2 Patent patents were all in … when the Patent Office’s Patent Trial and Appeal Board (“PTAB”) invalidated the 688 Patent on the grounds | External link to document |
2020-05-11 | 109 | Order on Motion to Dismiss | After the ’688 patent was issued, generics manufacturers sued to invalidate it. Dkt. No. 10 …intentionally withheld [prior art] from the Patent Office,” Dkt. No. 10 ¶ 15, and … 7 Raytheon Co., 816 F.3d 565, 574 (9th Cir. 2016); see also Schindler, 563 U.S…defendants fraudulently obtained U.S. Patent No. 8,865,688 (the “’688 patent”), which … 18 Patent and Trademark Office (“USPTO”) issued the ’688 patent, which has been assigned | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |